MDS Virtual Congress 2021 Archives - Page 57 of 132

MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

Qualitative Interviews With Children/Adolescents With Dyskinetic Cerebral Palsy (DCP) and Their Caregivers

D. Claassen, H. Riordan, L. Dure, R. Battini, A. Cortez, M. Gordon, M. O’Connor, K. Jackson, A. Foster, M. Kosinski (Nashville, USA)
Quality of life after Globus Pallidus vs Subthalamic nucleus DBS; insights from the Parkinson’s Outcomes Project registry.

A. Ramirez-Zamora, M. Rafferty, N. Dahodwala, M. Neault, A. Naito, J. Beck, R. de Leon, S. Wu, C. Marras, T. Thomas (Gainesville, USA)
Quality of Life, Perceived Social Support and Caregiver Burden in Parkinson’s Disease

P. Thomas, A. R, B. B, R. Yadav, V. Holla, N. Kamble, P. Pal (Bangalore, India)
Quantification of neck and trunk tilt during standing in Parkinson’s disease

H. Matsumoto, M. Shiraishi, H. Mizukami, S. Hino, M. Kaburagi, J. Ono, R. Nakagawa, K. Warashina, S. Mizuno, S. Tochimoto, Y. Yamano (Kawasaki, Japan)
Quantifying Tremor in the R6/2 Mouse model of Huntington’s Diease

H. Skelton, D. Grogan, J. Rubiano, R. Gross, C. Gutekunst (Atlanta, USA)
Quantitative 3D movement analysis detects motor improvement earlier than MDS-UPDRS in a levodopa challenge test

R. Barbosa, M. Medonça, R. Oliveira, M. Santos, A. Abreu, P. Bastos, P. Pita-Lobo, A. Valadas, L. Correia-Guedes, J. Ferreirajos, M. Rosa, R. Matias, M. Coelho (Lisbon, Portugal)
Quantitative downgaze palsy predicts the survival duration in patients with progressive supranuclear palsy

T. Xie, C. Yuen, W. Kang, M. Padmanaban, T. Han, J. Nichols (Chicago, USA)
Quantitative gait analysis using a pose-estimation algorithm with a single 2D-video of PD patients

JH. Shin, R. Yu, JN. Ong, CY. Lee, SH. Jeon, HP. Park, HJ. Kim, JH. Lee, B. Jeon (Seoul, Republic of Korea)
Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders

P. Zhang, J. Chen, T. Cai, Y. Zhang (Guangzhou, China)
Quantitative systems pharmacology modelling of Parkinson’s disease to compare anti-α-synuclein therapeutics

S. Bakshi, PH. Vander Graaf (Breda, Netherlands)